Remicade - (Infliximab) Products
REMICADE® (infliximab) belongs to a class of biologic medications known as TNF-blockers. REMICADE binds to TNF-alpha, blocking its action. Excess amounts of TNF-alpha causes the immune system to attack healthy cells in the GI tract, resulting in inflammation.
Nufactor carries REMICADE (Infliximab):
Product
Manufacturer
FDA-Approved Indication
IMMUNOSUPPRESSANT
Product: REMICADE® (Infliximab)
Manufacturer: Janssen Biotech, Inc.
FDA-Approved Indication:
Rheumatoid Arthritis,
Crohn's Disease,
Pediatric Crohn's Disease,
Ankylosing Spondylitis,
Psoriatic Arthritis,
Plaque Psoriasis,
Ulcerative Colitis,
Pediatric Ulcerative Colitis
Crohn's Disease,
Pediatric Crohn's Disease,
Ankylosing Spondylitis,
Psoriatic Arthritis,
Plaque Psoriasis,
Ulcerative Colitis,
Pediatric Ulcerative Colitis
